Anneliese Gonzalez

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Human endotrophin as a driver of malignant tumor growth

Dawei Bu, Clair Crewe, Christine M. Kusminski et al. · JCI Insight · 2019 · 67 citations · Full text

Human Endotrophin, Immunology, Pathology +19

The Effect of Age on Race-Related Breast Cancer Survival Disparities

Curtis J. Wray, Uma R. Phatak, Emily K. Robinson et al. · Annals of Surgical Oncology · 2013 · 60 citations

Aging, Longevity, Epidemiology Of Cancer +7

A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy

Xuejun Fan, Randall J. Brezski, Ming Fa et al. · Breast Cancer Research · 2012 · 58 citations · Full text

Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples

Scott A. Tomlins, Daniel H. Hovelson, Jennifer M. Suga et al. · JCO Precision Oncology · 2021 · 33 citations · Full text